Paul C. Grint
2017 - Regulus Therapeutics
In 2017, Paul C. Grint earned a total compensation of $1.7M as Former President and Chief Executive Officer at Regulus Therapeutics, a 40% decrease compared to previous year.
Compensation breakdown
| Option Awards | $927,226 |
|---|---|
| Salary | $190,365 |
| Other | $595,063 |
| Total | $1,712,654 |
Grint received $927.2K in option awards, accounting for 54% of the total pay in 2017.
Grint also received $190.4K in salary and $595.1K in other compensation.
Rankings
In 2017, Paul C. Grint's compensation ranked 6,289th out of 14,666 executives tracked by ExecPay. In other words, Grint earned more than 57.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,289 out of 14,666 | 57th |
Division Manufacturing | 2,315 out of 5,768 | 60th |
Major group Chemicals And Allied Products | 734 out of 2,074 | 65th |
Industry group Drugs | 567 out of 1,730 | 67th |
Industry Pharmaceutical Preparations | 446 out of 1,329 | 66th |
Source: SEC filing on April 20, 2018.
Grint's colleagues
We found four more compensation records of executives who worked with Paul C. Grint at Regulus Therapeutics in 2017.